- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02966509
Engagement of Patients With Advanced Cancer (EPAC)
October 4, 2018 updated by: Manali Indravadan Patel, Stanford University
The Engagement of Patients with Advanced Cancer is an intervention that utilizes well-trained lay health coaches to engage patients and their families in goals of care and shared decision-making after a diagnosis of advanced cancer.
Although lay health workers have never been tested in this role, we hypothesize that lay health workers can feasibly improve goals of care documentation and help to reduce unwanted healthcare utilization at the end of life for Veterans diagnosed with new advanced stages of cancer and those diagnosed with recurrent disease.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
VAPAHCS proposes to implement and evaluate several critical elements to be in alignment with the VHA's Strategic Goal and priority areas for FY2013.
The Engagement of Patients with Advanced Cancer project is an innovative program that will strengthen provider-patient relationship and facilitate whole person care about matters important to Veterans with cancer and important to support network and family.
The project is intended to help establish Goals of Care Plan with appropriate documentation, develop, deploy, and evaluate a model of care for persons with cancer that is intended to improve clinical outcomes and experience of care for individuals with advanced cancer who have advanced cancer (stages III, IV or recurrent disease).
The intervention provides patients with lay health coaches who assist patients and their families in discussing goals of care and engage in shared-decision making.
The goal of the project is to demonstrate that there is improved patient experiences, outcomes, and that the program helps to reduce utilization of health care resources at the end of life.
Study Type
Interventional
Enrollment (Actual)
213
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Newly diagnosed stage III or IV cancer
- Recurrent disease (any stage)
- Ability to consent to study
Exclusion Criteria:
- Patients who are unable to consent to study procedures
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: A: Intervention Arm
All participants randomized to Arm A will receive the EPAC intervention as well as usual oncologic care.
|
Each patient will receive a lay health worker who will engage and educate patients on goals of care documentation and will continue to address goals of care for at least 6 months with patients after enrollment in the study.
|
|
No Intervention: B: Control Group Arm
All participants randomized to Arm B will receive usual oncologic care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With Completed Goals of Care Documentation. We Will Evaluate if 75% of Patients in the Intervention Arm Have a Documented Goals of Care Titled Medical Note Within 6 Months of Patient Enrollment in the Study.
Time Frame: 6 months after each patient enrollment
|
Feasibility is defined as at least 75% of patients in the intervention arm with a documented Goals of Care titled medical note within 6 months of patient enrollment in the study.
|
6 months after each patient enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Emergency Department Visit (Chart Review)
Time Frame: 6 months after patient enrollment
|
Emergency Department Use for each patient will be abstracted by electronic medical record chart review for each patient at 6 months after enrollment.
|
6 months after patient enrollment
|
|
Emergency Department Visit (Chart Review)
Time Frame: 15 months after patient enrollment
|
Emergency Department Use for each patient will be abstracted by electronic medical record chart review for each patient at 15 months after enrollment.
|
15 months after patient enrollment
|
|
Hospitalization Visits (Chart Review)
Time Frame: 6 months after patient enrollment
|
Hospitalization use for each patient will be abstracted by electronic medical record chart review for each patient at 6 months after enrollment.
|
6 months after patient enrollment
|
|
Hospitalization Visits (Chart Review)
Time Frame: 15 months after patient enrollment
|
Hospitalization use for each patient will be abstracted by electronic medical record chart review for each patient at 15 months after enrollment.
|
15 months after patient enrollment
|
|
Hospice Referral (Chart Review)
Time Frame: 6 months after patient enrollment
|
Hospice referral for each patient will be abstracted by electronic medical record chart review for each patient at 6 months after enrollment.
|
6 months after patient enrollment
|
|
Palliative Care Referral (Chart Review)
Time Frame: 6 months after patient enrollment
|
Palliative Care Referral for each patient will be abstracted by electronic medical record chart review for each patient at 6 months after enrollment.
|
6 months after patient enrollment
|
|
Palliative Care Referral (Chart Review)
Time Frame: 15 months after patient enrollment
|
Palliative Care Referral for each patient will be abstracted by electronic medical record chart review for each patient at 15 months after enrollment.
|
15 months after patient enrollment
|
|
Change in Patient Satisfaction With Care Using the Consumer Assessment of Health Care Providers and Systems -General Survey
Time Frame: Change in Patient Satisfaction with Care from baseline to 6 months.
|
Each patient will receive a satisfaction with care survey (The Consumer Assessment of Health Care Providers and Systems - General (CAHPS)) at baseline and 6 months.
We will measure the change in satisfaction from baseline to 6 months.
Scores for satisfaction were assessed using the Consumer Assessment of Healthcare Providers and Systems-General survey question #18 which measured rating of health provider, on which scores range from 0 to 10, with higher ratings correspond to higher patient satisfaction.
Scores for each group are averaged at baseline and at 6 months.
|
Change in Patient Satisfaction with Care from baseline to 6 months.
|
|
Patient Satisfaction With Decision-Making Using the Satisfaction With Decision Survey
Time Frame: 6 months
|
Each patient will receive a validated satisfaction with decision-making survey (The Satisfaction with Decision Survey) at 6 months after study enrollment.Satisfaction with Decision was assessed with the use of the 6-question Satisfaction with Decision Scale, on which scores range from 0 to 5, with higher scores indicating better satisfaction with decision-making.
Scores for each group are averaged at 6 months after study enrollment.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2013
Primary Completion (Actual)
December 1, 2016
Study Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
October 10, 2016
First Submitted That Met QC Criteria
November 15, 2016
First Posted (Estimate)
November 17, 2016
Study Record Updates
Last Update Posted (Actual)
October 31, 2018
Last Update Submitted That Met QC Criteria
October 4, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Respiratory Tract Diseases
- Neoplasms by Histologic Type
- Lung Diseases
- Urologic Neoplasms
- Urogenital Neoplasms
- Neoplasms by Site
- Kidney Diseases
- Urologic Diseases
- Neoplasms, Glandular and Epithelial
- Endocrine System Diseases
- Gonadal Disorders
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Gastrointestinal Diseases
- Endocrine Gland Neoplasms
- Genital Neoplasms, Male
- Testicular Diseases
- Respiratory Tract Neoplasms
- Thoracic Neoplasms
- Astrocytoma
- Glioma
- Neoplasms, Neuroepithelial
- Neuroectodermal Tumors
- Neoplasms, Germ Cell and Embryonal
- Neoplasms, Nerve Tissue
- Intestinal Diseases
- Intestinal Neoplasms
- Rectal Diseases
- Colorectal Neoplasms
- Neoplasms
- Kidney Neoplasms
- Testicular Neoplasms
- Head and Neck Neoplasms
- Lung Neoplasms
- Glioblastoma
- Death
- Rectal Neoplasms
Other Study ID Numbers
- EPAC1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.